β2受体激动剂与抗胆碱能药物治疗COPD药学探讨.docVIP

精品论文 参考文献 β2受体激动剂与抗胆碱能药物治疗COPD药学探讨 代勇 　　九○三医院 四川省江油市 621700 　　摘要：目的：探讨在COPD患者临床治疗过程中，beta;2受体激动剂与抗胆碱能药物临床治疗效果，旨在促进COPD患者病情快速痊愈。方法：选取2014年1月至2015年2月我院收治的COPD患者70例，这70例患者都在我院进行诊断和治疗，随机均匀分组，观察组患者35例，主要进行beta;2受体激动剂与抗胆碱能药物治疗，对照组患者35例，主要进行常规临床治疗，观察研究两组患者的临床治疗效果。结果：经过临床诊断和治疗，在患者肺功能改善有效情况上，观察组明显比对照组要好，在患者临床治疗有效率上，观察组明显高于对照组，且在患者后期不良反应发生情况上，观察组也明显优于对照组。结论：在COPD患者临床治疗过程中，beta;2受体激动剂与抗胆碱能药物治疗方法的应用效果是比较好的，不仅可以明显提升患者临床治疗有效率，还能有效改善患者临床症状和肺功能相关情况。 　　关键词：beta;2受体激动剂；抗胆碱能药物；治疗；COPD；药学探讨 　　[abstract]objective：to study in the process of clinical treatment of patients with COPD，beta 2 agonists and clinical therapeutic effect of anticholinergic drugs aimed at promoting the COPD patients recovered quickly.Selection methods：between January 2014 and February 2014，our hospital 70 cases of COPD patients，all 70 patients in our hospital for diagnosis and treatment，uniform random grouping，the observation group of 35 cases of patients with primary beta 2 agonists and anticholinergic drug treatment，35 patients with the control group，mainly for routine clinical treatment，observed the clinical treatment effect of two groups of patients.Results：through clinical diagnosis and treatment of lung function in patients with improving effective situation，observation group obviously better than the control group，effectively in clinical treatment，observation group is significantly higher than the control group，and adverse reactions occurred in the late patient conditions，the observation group is obviously better than the control group.Conclusion：in the process of clinical treatment of patients with COPD，beta 2 agonists and application effect of anticholinergic drug treatment is good，not only can obviously improve the clinical treatment efficiently，also can effectively improve the clinical symptoms and lung function. 　　Key words：beta 2 agonists；Anticholinergic drugs；Treatment；COPD；Medicine to discuss 　　本研究为了找出相对来说比较好的COPD疾病临床药物治疗方法，有效改善患者病情，提升患者的日常生活质量，选取我院收治的COPD患者70例作为研究参与人员进行相关研究和分析： 　　1资料与方法 　　1.1一般资料